首发精神病患者对抗精神病药物的不依从。
Non-adherence to antipsychotic medication in first-episode psychosis patients.
机构信息
Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK; Unit for Social & Community Psychiatry, World Health Organization Collaborating Centre for Mental Health Service Development, Queen Mary University of London, London, UK.
Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK.
出版信息
Psychiatry Res. 2018 Jun;264:151-154. doi: 10.1016/j.psychres.2018.04.002. Epub 2018 Apr 3.
This study evaluated the influence of attitudes and beliefs towards antipsychotics on adherence, and aimed to understand how satisfaction with information impacts adherence in first-episode psychosis. Fifty randomly selected out-patients attending the COAST Early Intervention service completed a survey comprised of the Selwood Compliance Scale, Beliefs about Medicines Questionnaire, and the Satisfaction with Information about Medicines Scale. Thirty-four percent of patients reported non-adherence to antipsychotic medication, and they were significantly younger than adherent patients. Adherent patients were more satisfied with medication information than non-adherent patients (65.7% and 34.3% respectively), suggesting that providing better information about antipsychotics may improve adherence.
这项研究评估了患者对抗精神病药物的态度和信念对其服药依从性的影响，并旨在了解对信息的满意度如何影响首发精神分裂症患者的服药依从性。50 名随机选择的在 COAST 早期干预服务中心就诊的门诊患者完成了一项调查，其中包括 Selwood 依从性量表、药物信念问卷和药物信息满意度量表。34%的患者报告不遵守抗精神病药物治疗，他们比依从性患者明显年轻。依从性患者对药物信息的满意度明显高于不依从性患者（分别为 65.7%和 34.3%），这表明提供更好的抗精神病药物信息可能会提高患者的服药依从性。
Zotero 插件